Bovidec Injection (5 dose)

Directions for Use

(i) Adult breeding cattle

For the active immunisation of female breeding cattle, by vaccination prior to service/insemination as an aid in the prevention of infection with BVD Type I virus during the first trimester of pregnancy. It is during this period that such infections can lead to persistent infection of the foetus with BVDV, a pre-requisite for Mucosal Disease (MD) in later life. Results from studies available to date indicate that the protection afforded against BVDV Type I should exist for at least 420 days post initial vaccination.

(ii) Calves

For the active immunisation of calves as an aid in the prevention of viraemia and to reduce viral shedding of BVD Type I virus, once maternal antibodies have declined.
The duration of immunity is 13 months.

For the active immunisation of calves to reduce viraemia and the clinical signs of disease caused by Bovine Viral Diarrhoea Virus Type II, once maternal antibodies have declined. Results from studies available to date indicate the reduction in symptoms afforded should exist for at least 21 days following vaccination course.

(iii) Reduction in the incidence of herd infertility

It has been shown under field conditions that the vaccine may reduce the incidence of herd infertility when a diagnosis of infertility is associated with clinical manifestations of BVD Type I infection.